Name: Climb Bio, Inc. (CLYM) Balance Sheet
Creator: FinSpry

Climb Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Climb Bio, Inc. (CLYM) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	87.23	93.11	123.57	136.48	20.49
Short-Term Investments	63.69	13.69	79.98	89.56	0.00
Cash & Short-Term Investments	150.92	106.80	123.57	136.48	20.49
Accounts Receivable	1.12	2.46	6.49	6.52	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.72	0.11	6.49	6.52	1.50
Total Current Assets	154.87	110.26	134.39	148.25	22.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.49	0.20	0.47	0.00	0.00
Long-Term Investments	61.61	0.00	0.00	24.92	0.00
Other Non-Current Assets	0.22	0.02	0.13	0.07	2.63
Total Non-Current Assets	62.32	0.21	0.60	24.99	0.00
Total Assets	217.19	110.47	134.99	173.24	24.63
Current Liabilities
Accounts Payable	0.71	0.07	5.80	6.03	1.29
Short-Term Debt	0.16	0.00	0.00	0.00	0.00
Accrued Liabilities	4.04	2.30	5.05	4.63	1.22
Other Current Liabilities	0.03	0.14	0.00	0.04	0.00
Total Current Liabilities	4.93	2.83	6.10	6.03	2.51
Non-Current Liabilities
Long-Term Debt	0.38	0.02	0.18	0.00	0.00
Other Non-Current Liabilities	0.00	0.02	0.00	0.01	0.00
Total Non-Current Liabilities	0.38	0.04	0.18	0.01	0.00
Total Liabilities	5.31	2.87	6.28	6.04	2.51
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00
Retained Earnings	-229.88	-155.98	-121.22	-75.74	-28.14
Accumulated Other Comprehensive Income	0.02	0.00	-0.36	-0.12	0.00
Additional Paid-in Capital	441.73	263.58	249.93	242.94	0.00
Shares Outstanding	67.26	27.70	26.57	26.24	0.00
Total Stockholders' Equity	211.88	107.60	128.72	167.20	22.12
Total Liabilities & Equity	217.19	110.47	134.99	173.24	0.00